CASH FLOWS FROM OPERATING ACTIVITIES: | |
Net earnings | |
(Earnings)/loss from discontinued operations | |
Earnings from continuing operations | |
Adjustments to reconcile earnings from continuing operations to net cash from operations: | |
Depreciation and amortization | |
Loss on extinguishment of debt | |
Gain on sale of investment in CareFusion | |
Impairments and loss on sale of assets | |
Share-based compensation | 23M |
Provision for deferred income taxes | |
Provision for bad debts | 7M |
Change in operating assets and liabilities, net of effects from acquisitions: | |
Decrease/(increase) in trade receivables | -306M |
Decrease/(increase) in inventories | -298M |
Increase/(decrease) in accounts payable | 279M |
Other accrued liabilities and operating items, net | -87M |
Net cash provided by operating activities-continuing operations | |
Net cash provided by/(used in) operating activities-discontinued operations | |
Net cash provided by operating activities | 104M |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
Proceeds from divestitures and sale of property and equipment | |
Acquisition of subsidiaries, net of cash acquired | -9M |
Purchase of held-to-maturity investment securities | |
Additions to property and equipment | -100M |
Proceeds from sale of CareFusion common stock | |
Proceeds from maturities of held-to-maturity securities | |
Net cash provided by/(used in) investing activities-continuing operations | |
Net cash used in investing activities-discontinued operations | |
Net cash provided by/(used in) investing activities | -110M |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
Payment of contingent consideration | 0 |
Net change in short-term borrowings | |
Reduction of long-term obligations | -1M |
Proceeds from long-term obligations, net of issuance costs | |
Proceeds from issuance of Common Shares | |
Tax disbursements from exercises of stock options | 30M |
Payment of premiums for debt extinguishment | |
Dividends on Common Shares | -149M |
Purchase of treasury shares | -250M |
Net cash used in financing activities-continuing operations | |
Net cash provided by/(used in) financing activities-discontinued operations | |
Net cash used in financing activities | -350M |
NET INCREASE/(DECREASE) IN CASH AND EQUIVALENTS | -355M |
CASH AND EQUIVALENTS AT BEGINNING OF YEAR | 2.36B |
CASH AND EQUIVALENTS AT END OF YEAR | 2B |
SUPPLEMENTAL INFORMATION: | |
Interest | |
Income taxes | |
Non-cash investing and financing transactions for: | |
Retained investment in CareFusion at date of Spin-Off | |
Non-cash dividend in connection with Spin-Off |